Downtrend on the daily chart: below its 50- and 200-day averages · 50-day below the 200-day · SuperTrend down since Jun 23 · below the Ichimoku cloud · RSI 26 (oversold) · MACD below its signal · 1% above its 52-week low
| 4.70 | 52-week high | +883.69% |
| 0.9580 | Previous month high | +100.29% |
| 0.6500 | Previous week high | +35.90% |
| 0.6300 | Previous month low | +31.72% |
| 0.5373 | R3 (classic) | +12.34% |
| 0.5310 | Previous week low | +11.02% |
| 0.5237 | R2 (classic) | +9.48% |
| 0.5100 | Previous day high | +6.63% |
| 0.5073 | R1 (classic) | +6.07% |
| 0.4937 | Pivot | +3.21% |
| 0.4800 | Previous day low | +0.36% |
| 0.4783 | Price now | |
| 0.4773 | S1 (classic) | −0.20% |
| 0.4715 | 52-week low | −1.42% |
| 0.4637 | S2 (classic) | −3.06% |
| 0.4473 | S3 (classic) | −6.47% |
| Investor | Value | Of portfolio | Shares | Change | Quarter |
|---|---|---|---|---|---|
| ARK Investment Management · Cathie Wood | $935.7K | 0.01% | 806.61K | +10.0% | Q2 2026 |
From each investor's quarterly 13F filing with the SEC: positions at the quarter's end, reported up to 45 days later. All investors
No member of Congress has disclosed a NNOX trade since 2025.
From House and Senate STOCK Act reports. Members disclose trades, not holdings, as value ranges up to 45 days later, so amounts are estimates and “last move” is a hint at who still holds it, not a position. All recent congress trades
| Date | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 13, 2026 | Saban SharonOfficer | Stock Award(Grant) at price 0.00 per share. | 28.3K | — |
| Oct 13, 2026 | Yahav Attias GaliOfficer | Stock Award(Grant) at price 0.00 per share. | 28.3K | — |
| Oct 13, 2026 | Nathansohn GuyChief Financial Officer | Stock Award(Grant) at price 0.00 per share. | 50K | — |
| Oct 8, 2026 | Koren OfirOfficer | Stock Award(Grant) at price 0.00 per share. | 28.3K | — |
| Oct 8, 2026 | Cohen Tamar AharonOfficer | Stock Award(Grant) at price 0.00 per share. | 28.3K | — |
| Sep 14, 2026 | Meltzer Erez IChief Executive Officer | Purchase at price 0.69 per share. | 10K | $6.90K |
| Sep 13, 2026 | Suesskind Dan SDirector | Purchase at price 0.75 - 0.76 per share. | 60K | $45.30K |
| Sep 9, 2026 | Meltzer Erez IChief Executive Officer | Purchase at price 0.78 per share. | 10K | $7.80K |
| Aug 9, 2026 | Meltzer Erez IChief Executive Officer | Purchase at price 1.03 per share. | 9.4K | $9.73K |
| Jul 27, 2026 | Kainan NogaDirector | Purchase at price 0.90 per share. | 33K | $29.70K |
| Jul 26, 2026 | Suesskind Dan SDirector | Purchase at price 0.92 - 0.94 per share. | 50K | $46.50K |
| Jul 26, 2026 | Meltzer Erez IChief Executive Officer | Purchase at price 0.93 per share. | 36K | $33.48K |
| Jun 9, 2026 | Alroy ErezDirector | Sale at price 1.65 per share. | 678 | $1.12K |
| Sep 4, 2025 | Daniel RanChief Financial Officer | Purchase at price 3.65 per share. | 1K | $3.65K |
TimeframesDown on all 4 timeframes: no timeframe is holding up.
under a falling 21 EMA, 21 under 50
under a falling 21 EMA, 21 under 50
under a falling 21 EMA, 21 under 50
under a falling 21 EMA, 21 under 50
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -2.5 | -13.2 | -4.2 | -24.7 | 12.3 | -39.6 | -15.5 | -17.7 | -14.0 | -31.1 | −82.9% | ||
| 2025 | 1.1 | -15.0 | -19.3 | 0.7 | 1.8 | 1.0 | -8.9 | -17.8 | -4.4 | -1.9 | 23.4 | -37.5 | −61.1% |
| 2024 | -14.6 | 105.1 | -12.5 | -8.3 | -6.7 | -12.2 | 17.4 | -26.1 | -4.6 | -6.7 | 13.9 | 11.5 | +13.0% |
| 2023 | 24.9 | -20.9 | -20.9 | 5.9 | 191.2 | -12.9 | -19.9 | -32.9 | -21.2 | -23.0 | 32.7 | -4.9 | −13.7% |
| 2022 | -21.9 | -10.6 | 6.8 | -15.2 | 11.2 | 10.6 | 6.5 | 10.5 | -13.8 | 23.8 | -25.0 | -30.7 | −49.2% |
| 2021 | 66.0 | -40.3 | -8.4 | -19.1 | -25.5 | 28.2 | -11.5 | -13.0 | -8.8 | 0.7 | -8.9 | -29.5 | −68.2% |
| 2020 | -14.7 | 17.3 | 122.1 | -25.5 | +65.7% |
Buy / hold / sell counts
Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source. It provides teleradiology services and develops artificial intelligence applications to be used in real-world medical imaging applications. The company's solutions include Nanox Multi Source System comprising Nanox.ARC, a medical tomographic imaging system incorporating its digital X-ray source; and Nanox. CLOUD, a platform which employs a matching engine to match medical images to radiologists that provides image repository, connectivity to diagnostic assistive AI systems, billing, and reporting. It also offers Nanox.MARKETPLACE, which connects imaging facilities with radiologists and enables radiologists; Nanox.CONNECT to receive local regulatory approvals and explore and evaluate the business model and the potential service; artificial intelligence (AI)-based software imaging solutions to hospitals, health maintenance organizations, integrated delivery networks, pharmaceutical companies, and insurers that are designed to identify or predict undiagnosed or underdiagnosed medical conditions through the mining of data of existing computed tomography scans; and Teleradiology Services, which provide imaging interpretation services for radiology practices, hospitals, medical clinics, diagnostic imaging centers and mobile imaging service providers, urgent care facilities, and multi-specialty physician groups. In addition, the company provides Real+ Osteoporosis Care Management Platform, a osteoporosis care management software platform; AI-Based Aortic Valve Calcification Measurement, an artificial intelligencebased solution; AI-Based Body Composition Measurement, an artificial intelligencebased body composition analysis capability; and Nanox Health IT, a healthcare information technology services provider that serves hospitals and other healthcare organizations. Nano-X Imaging Ltd. was founded in 2011 and is headquartered in Petah Tikva, Israel.